Link Cell Therapies's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch Link Cell Therapies: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Link Cell Therapies funding history
No funding rounds for Link Cell Therapies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Link Cell Therapies valuation
Link Cell Therapies's last reported valuation was $111 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
How Link Cell Therapies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Link Cell Therapies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Link Cell Therapies
- What is Link Cell Therapies worth?
- Link Cell Therapies is valued at $110.5M as of Oct 2026. Link Cell Therapies's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- How much has Link Cell Therapies raised?
- Link Cell Therapies has raised $72.0M in total funding across its recorded rounds.